HomeMBRX • NASDAQ
Moleculin Biotech Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.94M | -10.99% |
Net income | -6.44M | -29.50% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.91M | 11.03% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.72M | -54.14% |
Total assets | 21.01M | -31.88% |
Total liabilities | 20.97M | 126.52% |
Total equity | 42.00K | — |
Shares outstanding | 14.13M | — |
Price to book | ∞ | — |
Return on assets | -78.32% | — |
Return on capital | -435.38% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -6.44M | -29.50% |
Cash from operations | -4.56M | 32.05% |
Cash from investing | — | — |
Cash from financing | 8.00M | — |
Net change in cash | 3.44M | 151.12% |
Free cash flow | -2.73M | 38.88% |
Previous close
$0.91
Day range
$0.85 - $0.89
Year range
$0.40 - $4.90
Market cap
12.28M USD
Avg Volume
324.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
17
